Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Negro

Showing results (211-220 of 231) with videos related to

Pageof 24
Sort By:
Transplantation Proceedings|February 1, 1989
In situ versus bench resection of liver allografts before orthotopic liver transplantationF Crucitti, I R Marino, G De Luca, et al.
Journal of Viral Hepatitis|January 23, 2015
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patientsA Martini, G Fattovich, M Guido, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
American Journal of Obstetrics and Gynecology|April 1, 1987
The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluidA Lightman, B C Tarlatzis, P J Rzasa, et al.
Journal of Hepatology|July 25, 2000
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3L Rubbia-Brandt, R Quadri, K Abid, et al.
Journal of Hepatology|July 14, 2001
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxisA Marzano, M Salizzoni, W Debernardi-Venon, et al.
Revue Medicale Suisse|July 24, 2014
[Cell transplantation: current treatments and future prospects]R P H Meier, Y D Muller, E M Gutzwiller, et al.
Journal of Viral Hepatitis|November 22, 2017
Trends in hepatitis C-related mortality in SwitzerlandO Keiser, F Giudici, B Müllhaupt, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Pageof 24

Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Transplantation Proceedings|February 1, 1989
In situ versus bench resection of liver allografts before orthotopic liver transplantationF Crucitti, I R Marino, G De Luca, et al.
Journal of Viral Hepatitis|January 23, 2015
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patientsA Martini, G Fattovich, M Guido, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
American Journal of Obstetrics and Gynecology|April 1, 1987
The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluidA Lightman, B C Tarlatzis, P J Rzasa, et al.
Journal of Hepatology|July 25, 2000
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3L Rubbia-Brandt, R Quadri, K Abid, et al.
Journal of Hepatology|July 14, 2001
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxisA Marzano, M Salizzoni, W Debernardi-Venon, et al.
Revue Medicale Suisse|July 24, 2014
[Cell transplantation: current treatments and future prospects]R P H Meier, Y D Muller, E M Gutzwiller, et al.
Journal of Viral Hepatitis|November 22, 2017
Trends in hepatitis C-related mortality in SwitzerlandO Keiser, F Giudici, B Müllhaupt, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Pageof 24